A carregar...
Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy
BACKGROUND: Endocrine therapy is one of the standard treatments for estrogen-receptor-positive breast cancer patients. Letrozole is the only aromatase inhibitor (AI) included in Thailand’s essential drug list since the change of reimbursement policy in 2008, when patients had to change their AIs (ot...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4154879/ https://ncbi.nlm.nih.gov/pubmed/25249759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S67553 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|